Spectral studies of the Ca2+-dependent interaction of trifluoperazine with S100b. 1989

P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
Department of Biological Sciences, Wayne State University, Detroit, Michigan 48202.

S100b is a calcium-binding protein that will bind to many calmodulin target molecules in a Ca2+-dependent manner. In order to study the Ca2+-dependent binding properties of S100b, its interaction with a calmodulin antagonist, trifluoperazine (TFP), was investigated using [19F]- and [1H]-NMR and UV-difference spectroscopy. It was estimated from [19F]-NMR that in the absence of Ca2+, the k1/2 value of TFP was 130 microM, while its k1/2 value decreased to 28 microM in the presence of Ca2+. The addition of KCl was not antagonistic to the Ca2+-dependent interaction of TFP to S100b. The chemical exchange rate of TFP with Ca2+-bound S100b was estimated to be 9 x 10(2) sec-1. By comparison with TFP-calmodulin exchange rates, it is suggested that the TFP-binding site on S100b is structurally different from its binding sites on calmodulin. Proton NMR resonance broadening in the range 6.8-7.2 ppm, corresponding to phenylalanine nuclei of S100b, indicates that these residues may be involved in TFP binding. Addition of Ca2+ to a 1:1 mixture of S100b and TFP resulted in a red-shifted UV-difference spectrum, while no significant difference spectrum was detected when Mg2+ was added to a S100b-TFP solution. Thus, we suggest that Ca2+ induces the exposure of a hydrophobic domain on S100b containing one or more phenylalanine residues that will bind TFP but that this domain is different from the hydrophobic domain on calmodulin.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009414 Nerve Growth Factors Factors which enhance the growth potentialities of sensory and sympathetic nerve cells. Neurite Outgrowth Factor,Neurite Outgrowth Factors,Neuronal Growth-Associated Protein,Neuronotrophic Factor,Neurotrophic Factor,Neurotrophic Factors,Neurotrophin,Neurotrophins,Growth-Associated Proteins, Neuronal,Neuronal Growth-Associated Proteins,Neuronotrophic Factors,Neurotrophic Protein,Neurotrophic Proteins,Proteins, Neuronal Growth-Associated,Factor, Neurite Outgrowth,Factor, Neuronotrophic,Factor, Neurotrophic,Factors, Nerve Growth,Factors, Neurite Outgrowth,Factors, Neuronotrophic,Factors, Neurotrophic,Growth Associated Proteins, Neuronal,Growth-Associated Protein, Neuronal,Neuronal Growth Associated Protein,Neuronal Growth Associated Proteins,Outgrowth Factor, Neurite,Outgrowth Factors, Neurite,Protein, Neuronal Growth-Associated
D009418 S100 Proteins A family of highly acidic calcium-binding proteins found in large concentration in the brain and believed to be glial in origin. They are also found in other organs in the body. They have in common the EF-hand motif (EF HAND MOTIFS) found on a number of calcium binding proteins. The name of this family derives from the property of being soluble in a 100% saturated ammonium sulfate solution. Antigen S 100,Nerve Tissue Protein S 100,S100 Protein,S-100 Protein,S100 Protein Family,Protein, S100,S 100 Protein
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D011485 Protein Binding The process in which substances, either endogenous or exogenous, bind to proteins, peptides, enzymes, protein precursors, or allied compounds. Specific protein-binding measures are often used as assays in diagnostic assessments. Plasma Protein Binding Capacity,Binding, Protein
D002135 Calcium-Binding Proteins Proteins to which calcium ions are bound. They can act as transport proteins, regulator proteins, or activator proteins. They typically contain EF HAND MOTIFS. Calcium Binding Protein,Calcium-Binding Protein,Calcium Binding Proteins,Binding Protein, Calcium,Binding Proteins, Calcium,Protein, Calcium Binding,Protein, Calcium-Binding
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D014268 Trifluoperazine A phenothiazine with actions similar to CHLORPROMAZINE. It is used as an antipsychotic and an antiemetic. Trifluoroperazine,Triftazin,Apo-Trifluoperazine,Eskazine,Flupazine,Stelazine,Terfluzine,Trifluoperazine HCL,Trifluoperazine Hydrochloride,Trifluperazine,Apo Trifluoperazine,ApoTrifluoperazine
D064568 S100 Calcium Binding Protein beta Subunit A calcium-binding protein that is 92 AA long, contains 2 EF-hand domains, and is concentrated mainly in GLIAL CELLS. Elevation of S100B levels in brain tissue correlates with a role in neurological disorders. NTP-S-100beta,Nerve Tissue Protein S 100, beta Subunit,Nerve Tissue Protein S 100b,Neural Protein S-100B,Neurotrophic Protein S100beta,Proteins, S-100b,S-100 Calcium-Binding Protein beta Subunit,S-100b Protein,S-100beta,S100beta Protein,NTP S 100beta,Neural Protein S 100B,Protein S-100B, Neural,Protein S100beta, Neurotrophic,Protein, S-100b,Protein, S100beta,Proteins, S 100b,S 100 Calcium Binding Protein beta Subunit,S 100b Protein,S 100beta,S-100B, Neural Protein,S-100b Proteins,S100beta, Neurotrophic Protein

Related Publications

P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
August 1983, FEBS letters,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
January 2010, Cardiovascular psychiatry and neurology,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
January 2018, Doklady. Biochemistry and biophysics,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
March 1985, FEBS letters,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
March 1998, Invertebrate neuroscience : IN,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
October 2004, FEBS letters,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
March 1996, Biochemical and biophysical research communications,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
June 1990, International journal of biological macromolecules,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
November 1979, Molecular pharmacology,
P L Pingerelli, and H Mizukami, and M J Mooney, and A L Schlaepfer
April 1999, The Journal of biological chemistry,
Copied contents to your clipboard!